Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of adrenal physiology (HP:0011733)help
Parent Node:
expand
Adrenal insufficiency (HP:0000846)help
..Starting node
..expand
Primary adrenal insufficiency (HP:0008207)help
Term ID: 8207
Name: Primary adrenal insufficiency
Synonym: Addison disease; Addison's disease; Adrenocortical insufficiency; Primary adrenocortical failure
Definition: Insufficient production of steroid hormones (primarily cortisol) by the adrenal glands as a result of a primary defect in the glands themselves.
Comments:
Reference: HP:0008207
Genes and Diseases:
 
       Child Nodes:
........expandDecreased circulating aldosterone level (HP:0004319) help
........expandDecreased circulating cortisol level (HP:0008163) help

 Sister Nodes: 
..expandCentral adrenal insufficiency (HP:0011734) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0008207HP:0008207Primary adrenal insufficiency0AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome57
HP:0008207HP:0008207Primary adrenal insufficiency0ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy135
HP:0008207HP:0008207Primary adrenal insufficiency0ABCD1 CL E G H21561ORPHA:139399AdrenomyeloneuropathyHP:0040283 - Occasional135
HP:0008207HP:0008207Primary adrenal insufficiency0ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040281 - Very frequent135
HP:0008207HP:0008207Primary adrenal insufficiency0AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0008207HP:0008207Primary adrenal insufficiency0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0008207HP:0008207Primary adrenal insufficiency0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0008207HP:0008207Primary adrenal insufficiency0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency112
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11B2 CL E G H15852592OMIM:203400Corticosterone methyloxidase type I deficiency73
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronism73
HP:0008207HP:0008207Primary adrenal insufficiency0CYP11B2 CL E G H15852592OMIM:610600Hypoaldosteronism, congenital, due to CMO II deficiency73
HP:0008207HP:0008207Primary adrenal insufficiency0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040283 - Occasional53
HP:0008207HP:0008207Primary adrenal insufficiency0GATB CL E G H51888849OMIM:618838COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41
HP:0008207HP:0008207Primary adrenal insufficiency0GATC CL E G H28345925068OMIM:618839COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD421
HP:0008207HP:0008207Primary adrenal insufficiency0GLI3 CL E G H27374319ORPHA:672Pallister-Hall syndromeHP:0040283 - Occasional270
HP:0008207HP:0008207Primary adrenal insufficiency0GLI3 CL E G H27374319OMIM:146510Pallister-Hall syndrome270
HP:0008207HP:0008207Primary adrenal insufficiency0HSD11B2 CL E G H32915209OMIM:218030Apparent mineralocorticoid excess14
HP:0008207HP:0008207Primary adrenal insufficiency0HSD11B2 CL E G H32915209ORPHA:320Apparent mineralocorticoid excess14
HP:0008207HP:0008207Primary adrenal insufficiency0HSD17B4 CL E G H32955213OMIM:261515D-bifunctional protein deficiency98
HP:0008207HP:0008207Primary adrenal insufficiency0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency34
HP:0008207HP:0008207Primary adrenal insufficiency0KANSL1 CL E G H28405824565ORPHA:36395817q21.31 microdeletion syndromeHP:0040283 - Occasional283
HP:0008207HP:0008207Primary adrenal insufficiency0KANSL1 CL E G H28405824565ORPHA:363965Koolen-De Vries syndrome due to a point mutationHP:0040283 - Occasional283
HP:0008207HP:0008207Primary adrenal insufficiency0MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiency94
HP:0008207HP:0008207Primary adrenal insufficiency0MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 194
HP:0008207HP:0008207Primary adrenal insufficiency0MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiency26
HP:0008207HP:0008207Primary adrenal insufficiency0MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 226
HP:0008207HP:0008207Primary adrenal insufficiency0MRPS7 CL E G H5108114499OMIM:617872Combined oxidative phosphorylation deficiency 34.12
HP:0008207HP:0008207Primary adrenal insufficiency0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0008207HP:0008207Primary adrenal insufficiency0NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndrome11
HP:0008207HP:0008207Primary adrenal insufficiency0NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiency13
HP:0008207HP:0008207Primary adrenal insufficiency0NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital.48
HP:0008207HP:0008207Primary adrenal insufficiency0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndrome79
HP:0008207HP:0008207Primary adrenal insufficiency0NR3C2 CL E G H43067979OMIM:605115Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy109
HP:0008207HP:0008207Primary adrenal insufficiency0PCSK1 CL E G H51228743OMIM:600955Proprotein convertase 1/3 deficiency65
HP:0008207HP:0008207Primary adrenal insufficiency0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0008207HP:0008207Primary adrenal insufficiency0PEX1 CL E G H51898850ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent169
HP:0008207HP:0008207Primary adrenal insufficiency0PEX1 CL E G H51898850ORPHA:912Zellweger syndromeHP:0040283 - Occasional169
HP:0008207HP:0008207Primary adrenal insufficiency0PEX10 CL E G H51928851ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent75
HP:0008207HP:0008207Primary adrenal insufficiency0PEX10 CL E G H51928851ORPHA:912Zellweger syndromeHP:0040283 - Occasional75
HP:0008207HP:0008207Primary adrenal insufficiency0PEX11B CL E G H87998853ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent4
HP:0008207HP:0008207Primary adrenal insufficiency0PEX11B CL E G H87998853ORPHA:912Zellweger syndromeHP:0040283 - Occasional4
HP:0008207HP:0008207Primary adrenal insufficiency0PEX12 CL E G H51938854ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent65
HP:0008207HP:0008207Primary adrenal insufficiency0PEX12 CL E G H51938854ORPHA:912Zellweger syndromeHP:0040283 - Occasional65
HP:0008207HP:0008207Primary adrenal insufficiency0PEX13 CL E G H51948855ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent66
HP:0008207HP:0008207Primary adrenal insufficiency0PEX13 CL E G H51948855ORPHA:912Zellweger syndromeHP:0040283 - Occasional66
HP:0008207HP:0008207Primary adrenal insufficiency0PEX14 CL E G H51958856ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent46
HP:0008207HP:0008207Primary adrenal insufficiency0PEX14 CL E G H51958856ORPHA:912Zellweger syndromeHP:0040283 - Occasional46
HP:0008207HP:0008207Primary adrenal insufficiency0PEX16 CL E G H94098857ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent59
HP:0008207HP:0008207Primary adrenal insufficiency0PEX16 CL E G H94098857ORPHA:912Zellweger syndromeHP:0040283 - Occasional59
HP:0008207HP:0008207Primary adrenal insufficiency0PEX19 CL E G H58249713ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent62
HP:0008207HP:0008207Primary adrenal insufficiency0PEX19 CL E G H58249713ORPHA:912Zellweger syndromeHP:0040283 - Occasional62
HP:0008207HP:0008207Primary adrenal insufficiency0PEX2 CL E G H58289717ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent82
HP:0008207HP:0008207Primary adrenal insufficiency0PEX2 CL E G H58289717ORPHA:912Zellweger syndromeHP:0040283 - Occasional82
HP:0008207HP:0008207Primary adrenal insufficiency0PEX26 CL E G H5567022965ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent106
HP:0008207HP:0008207Primary adrenal insufficiency0PEX26 CL E G H5567022965ORPHA:912Zellweger syndromeHP:0040283 - Occasional106
HP:0008207HP:0008207Primary adrenal insufficiency0PEX3 CL E G H85048858ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent47
HP:0008207HP:0008207Primary adrenal insufficiency0PEX3 CL E G H85048858ORPHA:912Zellweger syndromeHP:0040283 - Occasional47
HP:0008207HP:0008207Primary adrenal insufficiency0PEX5 CL E G H58309719ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent99
HP:0008207HP:0008207Primary adrenal insufficiency0PEX5 CL E G H58309719ORPHA:912Zellweger syndromeHP:0040283 - Occasional99
HP:0008207HP:0008207Primary adrenal insufficiency0PEX6 CL E G H51908859ORPHA:44Neonatal adrenoleukodystrophyHP:0040281 - Very frequent98
HP:0008207HP:0008207Primary adrenal insufficiency0PEX6 CL E G H51908859ORPHA:912Zellweger syndromeHP:0040283 - Occasional98
HP:0008207HP:0008207Primary adrenal insufficiency0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0008207HP:0008207Primary adrenal insufficiency0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0008207HP:0008207Primary adrenal insufficiency0QRSL1 CL E G H5527821020OMIM:618835COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40
HP:0008207HP:0008207Primary adrenal insufficiency0SCNN1B CL E G H633810600OMIM:177200Liddle syndrome 161
HP:0008207HP:0008207Primary adrenal insufficiency0SCNN1G CL E G H634010602OMIM:618114Liddle syndrome 257
HP:0008207HP:0008207Primary adrenal insufficiency0SERPINA6 CL E G H8661540OMIM:611489Corticosteroid-binding globulin deficiency4
HP:0008207HP:0008207Primary adrenal insufficiency0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0008207HP:0008207Primary adrenal insufficiency0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0008207HP:0008207Primary adrenal insufficiency0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0008207HP:0008207Primary adrenal insufficiency0STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiency45
HP:0008207HP:0008207Primary adrenal insufficiency0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0008207HP:0008207Primary adrenal insufficiency0TBX19 CL E G H909511596OMIM:201400Acth deficiency, isolated57
HP:0008207HP:0008207Primary adrenal insufficiency0TBX19 CL E G H909511596ORPHA:199296Congenital isolated ACTH deficiency57
HP:0008207HP:0008207Primary adrenal insufficiency0TCTN3 CL E G H2612324519ORPHA:2753Orofaciodigital syndrome type 4HP:0040283 - Occasional31
HP:0008207HP:0008207Primary adrenal insufficiency0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0008207HP:0008207Primary adrenal insufficiency0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0008207HP:0008207Primary adrenal insufficiency0TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiency85
HP:0008207HP:0008207Primary adrenal insufficiency0TXNRD2 CL E G H1058718155OMIM:617825GLUCOCORTICOID DEFICIENCY 5; GCCD585
HP:0008207HP:0004319Decreased circulating aldosterone level1AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome.57
HP:0008207HP:0008163Decreased circulating cortisol level1AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome.57
HP:0008207HP:0008163Decreased circulating cortisol level1ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040281 - Very frequent135
HP:0008207HP:0004319Decreased circulating aldosterone level1AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0008207HP:0004319Decreased circulating aldosterone level1AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0008207HP:0008163Decreased circulating cortisol level1AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0008207HP:0008163Decreased circulating cortisol level1BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0008207HP:0008163Decreased circulating cortisol level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0008163Decreased circulating cortisol level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0008207HP:0008163Decreased circulating cortisol level1CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040281 - Very frequent112
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11B2 CL E G H15852592OMIM:203400Corticosterone methyloxidase type I deficiency.73
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronismHP:0040282 - Frequent73
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP11B2 CL E G H15852592OMIM:610600Hypoaldosteronism, congenital, due to CMO II deficiency73
HP:0008207HP:0004319Decreased circulating aldosterone level1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0008207HP:0008163Decreased circulating cortisol level1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0008207HP:0008163Decreased circulating cortisol level1GATB CL E G H51888849OMIM:618838COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41
HP:0008207HP:0008163Decreased circulating cortisol level1GATC CL E G H28345925068OMIM:618839COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD421
HP:0008207HP:0008163Decreased circulating cortisol level1GLI3 CL E G H27374319OMIM:146510Pallister-Hall syndrome270
HP:0008207HP:0004319Decreased circulating aldosterone level1HSD11B2 CL E G H32915209OMIM:218030Apparent mineralocorticoid excess.14
HP:0008207HP:0004319Decreased circulating aldosterone level1HSD11B2 CL E G H32915209ORPHA:320Apparent mineralocorticoid excessHP:0040282 - Frequent14
HP:0008207HP:0004319Decreased circulating aldosterone level1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0008207HP:0008163Decreased circulating cortisol level1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0008207HP:0008163Decreased circulating cortisol level1MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate94
HP:0008207HP:0004319Decreased circulating aldosterone level1MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional94
HP:0008207HP:0008163Decreased circulating cortisol level1MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 1.94
HP:0008207HP:0004319Decreased circulating aldosterone level1MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional26
HP:0008207HP:0008163Decreased circulating cortisol level1MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate26
HP:0008207HP:0008163Decreased circulating cortisol level1MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 2.26
HP:0008207HP:0008163Decreased circulating cortisol level1NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0008207HP:0008163Decreased circulating cortisol level1NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndromeHP:0040281 - Very frequent11
HP:0008207HP:0004319Decreased circulating aldosterone level1NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional13
HP:0008207HP:0008163Decreased circulating cortisol level1NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate13
HP:0008207HP:0008163Decreased circulating cortisol level1NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital.48
HP:0008207HP:0004319Decreased circulating aldosterone level1NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital.48
HP:0008207HP:0004319Decreased circulating aldosterone level1NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040281 - Very frequent79
HP:0008207HP:0004319Decreased circulating aldosterone level1NR3C2 CL E G H43067979OMIM:605115Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy.109
HP:0008207HP:0008163Decreased circulating cortisol level1PCSK1 CL E G H51228743OMIM:600955Proprotein convertase 1/3 deficiency.65
HP:0008207HP:0008163Decreased circulating cortisol level1PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0008207HP:0008163Decreased circulating cortisol level1PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0008207HP:0008163Decreased circulating cortisol level1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040282 - Frequent76
HP:0008207HP:0008163Decreased circulating cortisol level1QRSL1 CL E G H5527821020OMIM:618835COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40
HP:0008207HP:0004319Decreased circulating aldosterone level1SCNN1B CL E G H633810600OMIM:177200Liddle syndrome 1.61
HP:0008207HP:0004319Decreased circulating aldosterone level1SCNN1G CL E G H634010602OMIM:618114Liddle syndrome 257
HP:0008207HP:0008163Decreased circulating cortisol level1SERPINA6 CL E G H8661540OMIM:611489Corticosteroid-binding globulin deficiency4
HP:0008207HP:0008163Decreased circulating cortisol level1SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0008207HP:0008163Decreased circulating cortisol level1SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0008207HP:0008163Decreased circulating cortisol level1SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0008207HP:0004319Decreased circulating aldosterone level1STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional45
HP:0008207HP:0008163Decreased circulating cortisol level1STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate45
HP:0008207HP:0008163Decreased circulating cortisol level1SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0008207HP:0008163Decreased circulating cortisol level1TBX19 CL E G H909511596OMIM:201400Acth deficiency, isolated.57
HP:0008207HP:0008163Decreased circulating cortisol level1TBX19 CL E G H909511596ORPHA:199296Congenital isolated ACTH deficiencyHP:0040280 - Obligate57
HP:0008207HP:0008163Decreased circulating cortisol level1TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0008207HP:0008163Decreased circulating cortisol level1TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0008207HP:0004319Decreased circulating aldosterone level1TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional85
HP:0008207HP:0008163Decreased circulating cortisol level1TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate85
HP:0008207HP:0008163Decreased circulating cortisol level1TXNRD2 CL E G H1058718155OMIM:617825GLUCOCORTICOID DEFICIENCY 5; GCCD585


Genes (56) :AAAS ABCD1 AIRE AKT1 BAP1 CYP11A1 CYP11B1 CYP11B2 CYP17A1 GATB GATC GLI3 HSD11B2 HSD17B4 HSD3B2 KANSL1 MC2R MRAP MRPS7 NF2 NFKB2 NNT NR0B1 NR3C1 NR3C2 PCSK1 PDGFB PEX1 PEX10 PEX11B PEX12 PEX13 PEX14 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PIK3CA POR QRSL1 SCNN1B SCNN1G SERPINA6 SMARCB1 SMARCE1 SMO STAR SUFU TBX19 TCTN3 TERT TRAF7 TXNRD2

Diseases (45) :OMIM:231550 OMIM:300100 ORPHA:139399 ORPHA:139396 OMIM:240300 ORPHA:3453 ORPHA:2495 ORPHA:168558 ORPHA:289548 OMIM:202010 ORPHA:90795 OMIM:203400 ORPHA:556030 OMIM:610600 ORPHA:90793 OMIM:618838 OMIM:618839 ORPHA:672 OMIM:146510 OMIM:218030 ORPHA:320 OMIM:261515 ORPHA:90791 ORPHA:363958 ORPHA:363965 ORPHA:361 OMIM:202200 OMIM:607398 OMIM:617872 ORPHA:293978 OMIM:300200 ORPHA:786 OMIM:605115 OMIM:600955 ORPHA:44 ORPHA:912 ORPHA:95699 OMIM:618835 OMIM:177200 OMIM:618114 OMIM:611489 OMIM:201400 ORPHA:199296 ORPHA:2753 OMIM:617825
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.